Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · IEX Real-Time Price · USD
21.09
+1.16 (5.85%)
Jun 2, 2023, 10:40 AM EDT - Market open

Enliven Therapeutics Stock Forecast

Stock Price Forecast

According to 1 stock analyst, the 12-month stock price forecast for ELVN stock stock is $27, which predicts an increase of 28.05%. On average, analysts rate ELVN stock stock as a strong buy.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $27 $27 $27 $27
Change +28.05% +28.05% +28.05% +28.05%
* Price targets were last updated on Mar 29, 2023.

Analyst Ratings

The average analyst rating for ELVN stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Mar '23Apr '23May '23
Strong Buy 111
Buy 111
Hold 000
Sell 000
Strong Sell 000
Total 222

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.88
from 0.24
EPS Next Year
-2.17
from -1.88
Year 20182019202020212022202320242025
Revenue
--------
Revenue Growth
--------
EPS
-64.56-133.60-14.12-9.480.24-1.88-2.17-2.41
EPS Growth
--------
No. Analysts -----555

Revenue Forecast

Revenue 202320242025
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202320242025
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202320242025
High -1.71 -2.12 -2.43
Avg -1.88 -2.17 -2.41
Low -2.15 -2.25 -2.35

EPS Growth

EPS Growth 202320242025
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.